[go: up one dir, main page]

Latest News for: Amarin

Edit

Amarin Reaffirms the Proven, Guideline-Recommended Role of VASCEPA� (Icosapent�Ethyl) in an�Evolving Triglyceride�Treatment Landscape

Nasdaq Globe Newswire 30 Jun 2026
Clinically Validated, Increasingly Prescribed, Widely Reimbursed, and ...
Edit

Statement of Changes in Beneficial Ownership (Form 4) (Amarin Corporation plc)

Public Technologies 30 Jun 2026
) FORM 4 ... Washington, D.C ... 2 ... AMARIN CORP PLC\UK [AMRN] 5 ... C/O AMARIN PHARMA, INC., 440 US HIGHWAY 22 3 ... C/O AMARIN PHARMA, INC ... Amarin Corporation plc published this content on June 30, 2026, and is solely responsible for the information contained herein.
Edit

Key Takeaways on Induced Patent Infringement After Supreme Court Decision in Hikma v. Amarin (Baker, Donelson, Bearman, Caldwell & Berkowitz PC)

Public Technologies 23 Jun 2026
) In an opinion authored by Justice Jackson earlier this month, a unanimous Supreme Court recently reversed the Federal Circuit and held that Amarin Pharma, Inc ... Section 271(b) ... Disclaimer ... (noodl. 132635812) .
Edit

The Skinny on the Supreme Court’s Decision in Patent Infringement Case Hikma v. Amarin (Greenberg Traurig LLP)

Public Technologies 05 Jun 2026
Amarin Pharma, Inc. Justice Jackson, writing for the Court, resolved a dispute over Hikma's generic version of Amarin's cardiovascular medication Vascepa®, holding that Amarin had not ...
Edit

Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (Supreme Court of the United States)

Public Technologies 04 Jun 2026
). The text version of this document is not available ... Attachments Permalink. Disclaimer.
Edit

Proxy Results (Form 8-K) (Amarin Corporation plc)

Public Technologies 15 May 2026
On May 13, 2026, Amarin Corporation plc (the "Company") held its Annual General Meeting of Shareholders (the "Annual Meeting") ... Amarin Corporation plc published this content on May ...
Edit

Amarin Reports 2026 First Quarter Financial Results (Form 8-K) (Amarin Corporation plc)

Public Technologies 29 Apr 2026
Amarin Reports 2026 First Quarter Financial Results ... DUBLIN, Ireland and BRIDGEWATER, N.J., April 29, 2026 -- Amarin Corporation plc (NASDAQ ... Amarin will host a conference call on April 29, 2026, at 8.00 a.m ... About Amarin.
Edit

Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q) (Amarin Corporation plc)

Public Technologies 29 Apr 2026
). Management's Discussion and Analysis of Financial Condition and Results of Operations ... Overview ... VASCEPA (U.S ... Amarin (US) ... Amarin Corporation plc published this content on April 29, 2026, and is solely responsible for the information contained herein.
Edit

Exhibit 63 - Amarin Pharma Inc. v. Apotex Inc. (The eRulemaking Program)

Public Technologies 21 Apr 2026
). The text version of this document is not available ... Disclaimer ... (noodl. 131089012) .
Edit

Amarin to Report First Quarter 2026 Financial Results and Host Conference Call on April 29, 2026

Enid News & Eagle 15 Apr 2026
... 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ.
Edit

Annual Report (Form ARS) (Amarin Corporation plc)

Public Technologies 10 Apr 2026
Amarin Corporation plc published this content on April 10, 2026, and is solely ...
Edit

Proxy Statement (Form DEF 14A) (Amarin Corporation plc)

Public Technologies 10 Apr 2026
AMARIN CORPORATION PLC ... Thank you for your continued support of Amarin ... In January 2021, Amarin adopted the Amarin Corporation plc Executive Severance and Change of Control Plan (the "Executive Severance Plan"), pursuant to which our U.S.
Edit

American College of Cardiology (ACC) Scientific Sessions 2026 Underscore the Need for

Hastings Tribune 08 Apr 2026
... 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ.
Edit

Management Change/Compensation (Form 8-K) (Amarin Corporation plc)

Public Technologies 27 Mar 2026
Amarin Corporation plc published this content on March 27, 2026, and is solely responsible for the information contained herein.

Article Search

tools
×
×
×
×